Clin2
NCT06781996Likely a fitRecruiting

Digital tool to help manage hormone therapy side effects

Breast CancerBreast Cancer Early Stage Breast Cancer (Stage 1-3)

Part of Cancer, Skin clinical trials.

This trial tests a digital tool (a smartphone app) to help women and men with early breast cancer manage side effects from hormone therapy. The goal is to improve quality of life during treatment.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
180 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are currently on hormone therapy for early-stage breast cancer (stages I–III).
  • You are experiencing side effects from your hormone therapy.
  • You have a smartphone and can read French.
  • You are 18 years or older and able to give informed consent.
  • You are not in another behavioral study or have severe cognitive issues.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06989450Recruiting
Digital support for women on hormone therapy for breast cancer

This trial tests a smartphone app called Sidekick to help women with early-stage breast cancer stick to their hormone therapy and feel more confident managing their health. If you were diagnosed with stage I, II, or III breast cancer after September 2023 and are starting hormone therapy, this program might help you stay on track.

Reykjavik
NCT06729684Recruiting
Digital health program for breast cancer side effects

This study is testing a personalized digital health program to help breast cancer survivors manage side effects. It uses a smartphone app to track symptoms and offer support.

Seoul, Republic of Korea
NCT06765707Enrolling by invitation
Monitoring symptoms to improve medication use in breast cancer

This trial tests if tracking how you feel and reporting your symptoms can help women with hormone receptor-positive breast cancer take their hormone-blocking medication more consistently. It may be a good fit if you have been prescribed aromatase inhibitors or similar therapy and have had trouble taking it as directed.

Chicago, Illinois
NCT07676591Not yet recruiting
EmpowerHer: digital support program for breast cancer survivors

This trial tests a smartphone-based program to help breast cancer survivors with exercise and wellness after finishing active treatment. It aims to improve your recovery and quality of life.

Valencia, Valencia
NCT07482384Recruiting
Support program for young women with early-stage breast cancer

This study tests a mobile health program that provides support and information to young women with early-stage breast cancer who are on hormone therapy. The goal is to help you stay on your treatment and manage side effects.

Boston, Massachusetts
NCT06424054Not yet recruiting
Monitoring side effects through a patient portal during breast cancer chemo

This trial tests if tracking your side effects through an online health portal helps reduce treatment-related problems. It's for people starting chemotherapy for breast cancer before or after surgery.

Hear when a new Breast cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.